Stempoint Capital Portfolio holdings

AUM $311M

1-Year Est. Return 15.22%

2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4

This Quarter Est. Return

1 Year Est. Return

+15.22%

3 Year Est. Return

5 Year Est. Return

10 Year Est. Return

AUM

$313M

AUM Growth

-$85.6M (-21%)

Cap. Flow

Cap. Flow % of AUM

Top 10 Holdings % Top 10 Hldgs %

Holding

New

Increased

Reduced

Closed

Top Buys

1		+$18M
2		+$13.6M
3		+$12.9M
4	BridgeBio Pharma BBIO	+$7.21M
5	CG Oncology CGON	+$7.1M

Top Sells

1		+$16.2M
2		+$15.7M
3		+$13.4M
4	Merus MRUS	+$11.3M
5	Praxis Precision Medicines PRAX	+$10.3M

Sector Composition

1	Healthcare	99.51%
2	Financials	0.49%

Communication Services

Advertising Agencies

Broadcasting

Electronic Gaming & Multimedia

Entertainment

Internet Content & Information

Publishing

Telecom Services

Consumer Discretionary

Apparel Manufacturing

Apparel Retail

Auto Manufacturers

Auto Parts

Auto & Truck Dealerships

Department Stores

Footwear & Accessories

Furnishings, Fixtures & Appliances

Gambling

Home Improvement Retail

Internet Retail

Leisure

Lodging

Luxury Goods

Packaging & Containers

Personal Services

Recreational Vehicles

Residential Construction

Resorts & Casinos

Restaurants

Specialty Retail

Textile Manufacturing

Travel Services

Consumer Staples

Beverages - Brewers

Beverages - Non-Alcoholic

Beverages - Wineries & Distilleries

Confectioners

Discount Stores

Education & Training Services

Farm Products

Food Distribution

Grocery Stores

Household & Personal Products

Packaged Foods

Tobacco

Energy

Oil & Gas Drilling

Oil & Gas Equipment & Services

Oil & Gas Exploration & Production

Oil & Gas Integrated

Oil & Gas Midstream

Oil & Gas Refining & Marketing

Thermal Coal

Uranium

Financials

Asset Management

Banks - Diversified

Banks - Regional

Capital Markets

Credit Services

Diversified Insurance

Financial Conglomerates

Financial Data & Stock Exchanges

Insurance Brokers

Life Insurance

Mortgage Finance

Property & Casualty Insurance

Reinsurance

Shell Companies

Specialty - Insurance

Healthcare

Biotechnology

Diagnostics & Research

Drug Manufacturers - General

Drug Manufacturers - Specialty & Generic

Healthcare Plans

Health Information Services

Medical Care Facilities

Medical Devices

Medical Distribution

Medical Instruments & Supplies

Pharmaceutical Retailers

Industrials

Aerospace & Defense

Airlines

Airports & Air Services

Building Products & Equipment

Business Equipment & Supplies

Conglomerates

Consulting Services

Electrical Equipment & Parts

Engineering & Construction

Farm & Heavy Construction Machinery

Industrial Distribution

Infrastructure Operations

Integrated Freight & Logistics

Marine Shipping

Metal Fabrication

Pollution & Treatment Controls

Railroads

Rental & Leasing Services

Security & Protection Services

Specialty Business Services

Specialty Industrial Machinery

Staffing & Employment Services

Tools & Accessories

Trucking

Waste Management

Materials

Agricultural Inputs

Aluminum

Building Materials

Chemicals

Coking Coal

Copper

Gold

Lumber & Wood Production

Other Industrial Metals & Mining

Other Precious Metals & Mining

Paper & Paper Products

Silver

Specialty Chemicals

Steel

Real Estate

Diversified REIT

Healthcare Facilities REIT

Hotel & Motel REIT

Industrial REIT

Mortgage REIT

Office REIT

Real Estate Development

Real Estate Diversified

Real Estate Services

Residential REIT

Retail REIT

Specialty REIT

Technology

Communication Equipment

Computer Hardware

Consumer Electronics

Electronic Components

Electronics & Computer Distribution

Information Technology Services

Scientific & Technical Instruments

Semiconductor Equipment & Materials

Semiconductors

Software - Application

Software - Infrastructure

Solar

Utilities

Diversified Utilities

Electric Utilities

Gas Utilities

Independent Power Producers

Renewable Electricity

Water Utilities

#	Name	Market Value	Portfolio Weight	Shares or Principal
1	1 Roivant Sciences ROIV $11.8B	$26M	8.29%	2,578,860 -133,918
2	2 Syndax Pharmaceuticals SNDX $1.23B	$19.6M	6.26%	1,598,594 -1,274,007
3	3 Scholar Rock SRRK $2.69B	$18.2M	5.8%	566,212 +399,905
4	4 Arcellx ACLX $4.82B	$18M	5.73%	+273,774
5	5 Merus MRUS $7.19B	$14.6M	4.65%	346,756 -268,056
6	6 Immunovant IMVT $3.05B	$14.6M	4.65%	853,472 -265,036
7	7 Madrigal Pharmaceuticals MDGL $9.78B	$13.6M	4.32%	+40,936
8	8 Nuvalent NUVL $6.67B	$13.5M	4.3%	190,401 +45,167
9	9 Revolution Medicines RVMD $10.1B	$11.3M	3.59%	318,782 +125,247
10	10 Janux Therapeutics JANX $1.61B	$9.24M	2.94%	342,062 +196,186
11	11 Xenon Pharmaceuticals XENE $3.21B	$9.21M	2.94%	274,633 -101,212
12	12 Denali Therapeutics DNLI $2.44B	$9.07M	2.89%	667,078 +82,750
13	CNTA 13 Centessa Pharmaceuticals CNTA $3.09B	$8.53M	2.72%	593,335 -48,629
14	14 uniQure QURE $3.57B	$7.75M	2.47%	731,039 +641,039
15	15 BridgeBio Pharma BBIO $10.5B	$7.21M	2.3%	+208,437
16	16 CG Oncology CGON $3.16B	$7.1M	2.26%	+289,823
17	SWTX 17 DELISTED SpringWorks Therapeutics SWTX	$7.03M	2.24%	+159,305
18	18 Arcutis Biotherapeutics ARQT $2.5B	$6.88M	2.19%	440,073 -60,893
19	19 Insmed INSM $35B	$6.64M	2.12%	87,059 -19,551
20	20 Alkermes ALKS $5B	$6.35M	2.02%	192,352 -224,616
21	21 Akero Therapeutics AKRO $4.32B	$6.32M	2.02%	+156,185
22	22 Biohaven BHVN $1.69B	$6.02M	1.92%	250,564 +64,151
23	23 Cytokinetics CYTK $6.99B	$6.01M	1.92%	149,648 +66,072
24	BPMC 24 DELISTED Blueprint Medicines BPMC	$5.48M	1.75%	+61,927
25	25 VistaGen Therapeutics VTGN $124M	$5.11M	1.63%	2,366,554 +38,062